IL6 and metabolic syndrome: GAL-3BP is significantly positively associated with inflammatory markers, including IL6, IL-1β, together with TNFα (11, 34, 35), and these may participate in MetS pathogenesis related to GAL-3BP, since inflammation may probably result in insulin resistance.